David A. Kaminsky
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David A. Kaminsky has a total of 383 co-authors. Here are the top co-authors by number of shared publications:
Charles G. Irvin
Department of Pulmonary and Critical Care Medicine University of Vermont Burlington Vermont USA
11 shared publications- Robert A. Wise
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
7 shared publications Anne E. Dixon
Pulmonary and Critical Care, University of Vermont Larner College of Medicine, Burlington, VT, USA
5 shared publications- Charles G. Irvin
Pulmonary and Critical Care, Given D208, 89 Beaumont Avenue, Burlington, VT USA 05405; Vermont Lung Center, 792 College Parkway, Suite 305, Colchester, VT USA 05446; University of Vermont Larner College of Medicine, Given D208, 89 Beaumont Avenue, Burlington, VT USA 05405
4 shared publications - Teal S. Hallstrand
University of Washington Division of Pulmonary, Critical Care and Sleep, 2Center for Lung Biology, Department of Medicine Seattle, WA
4 shared publications Charles G Irvin
Vermont Lung Center, Larner College of Medicine, University of Vermont, Burlington, VT, USA
3 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Wiley in Clinical & Experimental Allergy
T2 Inflammatory Profile in Relation to Lung Function Impairment in the General Population
Summary: T2 biomarkers showed respiratory physiology‐specific associations, particularly with airflow limitation, peripheral airway dysfunction, and air trapping. Combined eosinophils and FeNO elevation identified greater physiological impairment than individual biomarkers alone.
- 10 November 2026
- Published by Wiley in Clinical & Experimental Allergy
Open AccessT2 Inflammatory Profile in Relation to Lung Function Impairment in the General Population
Summary: T2 biomarkers showed respiratory physiology‐specific associations, particularly with airflow limitation, peripheral airway dysfunction, and air trapping. Combined eosinophils and FeNO elevation identified greater physiological impairment than individual biomarkers alone.
- 25 August 2026
- Published by Wiley in Journal of the American Geriatrics Society
The Effect of Blue Light Reduction on Delirium in Critically Ill Patients
- 25 August 2026
- Published by Wiley in Journal of the American Geriatrics Society
The Effect of Blue Light Reduction on Delirium in Critically Ill Patients
- 14 July 2026
- Published by SAGE Publications in Respiratory Care
- Vol. 71 (11) , 1302-1304
Language Disparities in the PFT Lab: Implications for PFT Lab Quality Performance
- 14 July 2026
- Published by SAGE Publications in Respiratory Care
- Vol. 71 (11) , 1302-1304
Language Disparities in the PFT Lab: Implications for PFT Lab Quality Performance
- Open Access
- 10 July 2026
- Published by Frontiers Media SA in Frontiers in Allergy
- Vol. 7, 1872486
It's not all about small airways disease: key limitations of oscillometry interpretation
An exciting aspect of oscillometry is the ability to detect small airways disease (SAD), particularly through frequency dependence of resistance, commonly measured as R5-R20. While SAD influences oscillometry measurements, it is important to realize that oscillometry is not specific for SAD. In addition, oscillometry measurements do not take into account lung volume, which can influence the measurements and make interpretation less clear. Finally, while oscillometry is very sensitive at detecting abnormalities of lung function, it is not specific for distinct lung diseases. These limitations should be considered when using oscillometry in respiratory physiology and medicine, where oscillometry provides valuable complimentary information to other lung function tests in evaluation of lung health.
- 10 July 2026
- Published by Frontiers Media SA in Frontiers in Allergy
- Vol. 7, 1872486
Open AccessIt's not all about small airways disease: key limitations of oscillometry interpretation
An exciting aspect of oscillometry is the ability to detect small airways disease (SAD), particularly through frequency dependence of resistance, commonly measured as R5-R20. While SAD influences oscillometry measurements, it is important to realize that oscillometry is not specific for SAD. In addition, oscillometry measurements do not take into account lung volume, which can influence the measurements and make interpretation less clear. Finally, while oscillometry is very sensitive at detecting abnormalities of lung function, it is not specific for distinct lung diseases. These limitations should be considered when using oscillometry in respiratory physiology and medicine, where oscillometry provides valuable complimentary information to other lung function tests in evaluation of lung health.
- 6 September 2025
- Published by Springer Nature
- p. 1-12
Breathing at Extremes of Temperature and Humidity
- 6 September 2025
- Published by Springer Nature
- p. 1-12
Breathing at Extremes of Temperature and Humidity
- 25 June 2025
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 46 (3)
What’s New in Pulmonary Function Testing?
- 25 June 2025
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 46 (3)
What’s New in Pulmonary Function Testing?
- 23 May 2025
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 46 (3) , 393-400
The History and Evolution of Pulmonary Function Testing Methods and Interpretation
- 23 May 2025
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 46 (3) , 393-400
The History and Evolution of Pulmonary Function Testing Methods and Interpretation
- 29 April 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 243, 108130
Longitudinal assessment of lung function in patients following COVID-19
- 29 April 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 243, 108130
Longitudinal assessment of lung function in patients following COVID-19